Senores Pharmaceuticals Limited has announced that the audio recording of its Earnings Conference Call for the quarter and nine months ended December 31, 2025, is now available. The conference call was held on January 20, 2026, with several Analysts, Institutional Investors, Funds, and other investors. Representing the company were Mr. Sanjay Majmudar, Chairman, Mr. Swapnil Shah, Managing Director, and Mr. Deval Shah, Whole Time Director and Chief Financial Officer (CFO). The audio recording can be accessed on the company's website at https://senorespharma.com/investor-meet/. The company has confirmed that no Unpublished Price Sensitive Information was shared or discussed during the call. This disclosure is made in compliance with Regulations 30 and 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
